These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27054372)

  • 1. Methamphetamine Vaccines: Improvement through Hapten Design.
    Collins KC; Schlosburg JE; Bremer PT; Janda KD
    J Med Chem; 2016 Apr; 59(8):3878-85. PubMed ID: 27054372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design.
    Gooyit M; Miranda PO; Wenthur CJ; Ducime A; Janda KD
    ACS Chem Neurosci; 2017 Mar; 8(3):468-472. PubMed ID: 27958709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequence of Hapten Stereochemistry: An Efficacious Methamphetamine Vaccine.
    Olson ME; Sugane T; Zhou B; Janda KD
    J Am Chem Soc; 2019 Sep; 141(36):14089-14092. PubMed ID: 31479256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of distinct chemical structures for the development of a methamphetamine vaccine.
    Moreno AY; Mayorov AV; Janda KD
    J Am Chem Soc; 2011 May; 133(17):6587-95. PubMed ID: 21473576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against haptens.
    Takatori T; Nagao M; Terazawa K
    Nihon Hoigaku Zasshi; 1992 Dec; 46(6):449-54. PubMed ID: 1303451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine against methamphetamine attenuates its behavioral effects in mice.
    Shen XY; Kosten TA; Lopez AY; Kinsey BM; Kosten TR; Orson FM
    Drug Alcohol Depend; 2013 Apr; 129(1-2):41-8. PubMed ID: 23022610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new strategy for improved nicotine vaccines using conformationally constrained haptens.
    Meijler MM; Matsushita M; Altobell LJ; Wirsching P; Janda KD
    J Am Chem Soc; 2003 Jun; 125(24):7164-5. PubMed ID: 12797775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a methamphetamine conjugate vaccine for antibody production in mice.
    Stevens MW; Gunnell MG; Tawney R; Owens SM
    Int Immunopharmacol; 2016 Jun; 35():137-141. PubMed ID: 27039212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of methamphetamine-specific antibody using biodegradable carboxymethyl-chitin.
    Tokura S; Hasegawa O; Nishimura S; Nishi N; Takatori T
    Anal Biochem; 1987 Feb; 161(1):117-22. PubMed ID: 3578777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.
    Carroll FI; Blough BE; Pidaparthi RR; Abraham P; Gong PK; Deng L; Huang X; Gunnell M; Lay JO; Peterson EC; Owens SM
    J Med Chem; 2011 Jul; 54(14):5221-8. PubMed ID: 21682289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against stimulants: cocaine and MA.
    Kosten T; Domingo C; Orson F; Kinsey B
    Br J Clin Pharmacol; 2014 Feb; 77(2):368-74. PubMed ID: 23509915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellin as carrier and adjuvant in cocaine vaccine development.
    Lockner JW; Eubanks LM; Choi JL; Lively JM; Schlosburg JE; Collins KC; Globisch D; Rosenfeld-Gunn RJ; Wilson IA; Janda KD
    Mol Pharm; 2015 Feb; 12(2):653-62. PubMed ID: 25531528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines.
    Duryee MJ; Bevins RA; Reichel CM; Murray JE; Dong Y; Thiele GM; Sanderson SD
    Vaccine; 2009 May; 27(22):2981-8. PubMed ID: 19428909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse.
    Collins KC; Janda KD
    Bioconjug Chem; 2014 Mar; 25(3):593-600. PubMed ID: 24521489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of a Heroin Vaccine through Hapten Deuteration.
    Belz TF; Bremer PT; Zhou B; Ellis B; Eubanks LM; Janda KD
    J Am Chem Soc; 2020 Aug; 142(31):13294-13298. PubMed ID: 32700530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.